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Abstract 
BACKGROUND: Systemic corticosteroid is used to treat alopecia areata, but it is associated with side effects. 
Mini-pulse therapy is thought to be effective but able to reduce side effects.  
AIM: The study aimed to evaluate the effectiveness of oral mini-pulse methylprednisolone in the treatment of 
alopecia areata.  
METHODS: Patients received methylprednisolone 16 mg orally for 2 consecutive days every week.  
RESULTS: After 3 months, among patients, 40% recovered well, and 55.6% recovered fairly. After 6 months, 
82.2% recovered well, 17.8% recovered fairly. No adverse events were detected, and the recurrence rate was low 
(2.2%).  
CONCLUSION: Oral mini-pulse methylprednisolone therapy is an effective and safe therapeutic option for 
alopecia areata without side effects, and the time of the treatment is short. 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
 
Alopecia areata is an autoimmune disease, 
affecting 0.2% of the world population, in both 
genders and all age groups but primarily in young 
people (aged 15-45), with an unclear aetiology [1]. 
The most characteristic symptom is hair loss in one or 
several small rounds or elliptic patches, without pain 
or itchy. Also, alopecia areata could also cause loss of 
pubic hair, beard, eyebrows and eyelashes [2].  
Systemic corticosteroid therapy has been 
used to therapy. Though it has beneficial effects, long-
term use leads to multiple and note side effects. Pulse 
and mini-pulse therapy have been introduced to treat 
several conditions, including alopecia areata, which 
have been shown to minimise the side effects of 
corticosteroids. The effectiveness of oral mini-pulse 
corticosteroids in treating alopecia areata has not 
been studied in Vietnam. 
The study aimed to evaluate the effectiveness 
of oral mini-pulse methylprednisolone in the treatment 
of alopecia areata. 
 
Methods  
 
We recruited a total of 45 patients with 
diagnosed alopecia areata by clinical symptoms, 
Clinical Science 
_______________________________________________________________________________________________________________________________ 
 
_______________________________________________________________________________________________________________________________ 
2                                                                                                                                                                                                   https://www.id-press.eu/mjms/index 
 
including hair loss in round or elliptic patches with no 
pain, itching, or scaling, age ≥ 15 years and with an 
indication to oral corticosteroids. The mini-pulse 
regimen was methylprednisolone 16 mg/day for two 
consecutive days every week for 6 months. All 
patients adhered to the study procedure and none 
dropped out. 
 
 
Results 
 
After 1 month, there were 5 patients (11.1%) 
recovered fairly. After 3 months, 40% recovered well 
(18 cases), and 55.6% recovered fairly (25 cases). 
After 6 months, 82.2% recovered well (35 cases), 
17.8% (8 cases) recovered fairly, and all these 
patients got better hair regrowth days every week as 
shown in Figure 1.  
 
Figure 1: Overall treatment outcome 
 
Severity and gender groups as shown in 
Table 1 and Table 2. 
Table 1: Outcome by severity 
Severity 
Outcome 
p Good Fair 
n % n % 
Mild 35 85.4 6 14.6 P > 0.05 
 Moderate 2 50 2 50 
 
After six months, no side effects were 
recorded. We had two patients developing new hair 
loss patches during study participation (one during the 
therapeutic stage and one during the follow-up stage). 
This rate was much lower than in patients treated with 
injected triamcinolone (9.9%). 
Table 2: Outcome by gender 
Gender 
Outcome 
p Good Fair 
n (%) n (%) 
Male 21 77.8 6 22.2 P > 0.05 
 Female  16 88.9 2 11.1 
 
 
Discussion 
 
In comparison with Doulat Rai Bajai’s [3] 
pulse prednisolone therapy concluding 30 mg per day 
within 3 days every week, and this treatment lasted for 
6 months. After Bajai’s treatment, among patients, 
85.6% recovered well, which is approximately 
equivalent with our result. Jea Won Jang and 
partners’ [4] pulse betamethasone therapy consisted 
in treatment in which patients took 5mg per day within 
two consecutive days every week. After a one-month 
treatment, 67.4% of patients got better. Pankaj [5] 
used pulse betamethasone (5 mg/day within two 
conservative days every week). After 6 months, 
73.3% of the patients recovered well. In another 
group, patients took 40 mg betamethasone once per 
month in 6 consecutive months, and 42.9% of the 
patients recovered well [6].  
In conclusion, oral mini-pulse 
methylprednisolone was effective, simple, with short-
term use of medication, and had no side effects. 
 
 
References 
 
1. Unal M. Use of adapalene in alopecia areata: Efficacy and 
safety of mometasone furoate 0.1% cream versus a combination of 
mometasone furoate 0.1% cream and adapalene 0.1% gel in 
alopecia areata. Dermatologic therapy. 2018; 31(1):e12574. 
https://doi.org/10.1111/dth.12574 PMid:29193637  
2. Craiglow BG. Topical tofacitinib solution for the treatment of 
alopecia areata affecting eyelashes. JAAD case reports. 2018; 
4(10):988. https://doi.org/10.1016/j.jdcr.2018.07.018 
PMid:30417059 PMCid:PMC6218694 
 
3. Bajaj DR, Devrajani BR, Shah SZ, Ghauri RA, Matlani BL. 
Treatment of extensive alopecia areata with oral prednisolone mini-
pulse regimen. Journal of Pakistan Association of Dermatology. 
2016; 18(4):226-31. 
 
4. Won Jang J, et al. Oral mini-pulse therapy with betamethasone 
in Treatment of Alopecia Areata. Department of Dermatology, 
Kyungpook, National University Scholl of Medicine, Taegu, Korea, 
2001. 
 
5. Chaturvedi P, et al. Comparative Efficacy an Safety of Twice 
weekly Oral Betamethasone Mini Pulse and Monthly Oral 
Betamethasone Pulse in Multifocal Alopecia Areata. Dermacon, 
India, 2010:P173. 
 
6. Gianfaldoni S, Tchernev G, Wollina U, Lotti T. A Case of 
Alopecia Areata in a Patient with Turner Syndrome. Open Access 
Maced J Med Sci. 2017; 5(4):493-496. 
https://doi.org/10.3889/oamjms.2017.127 PMid:28785342 
PMCid:PMC5535667 
 
 
 
 
 
 
 
 
 
 
 _______________________________________________________________________________________________________________________________ 
Open Access Maced J Med Sci.                                                                                                                                                                                                          3 
 
 
